Veliparib With or Without Carboplatin in Treating Patients With Stage IV Breast Cancer
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well veliparib with or without carboplatin works in treating
patients with stage IV breast cancer. Veliparib may stop the growth of tumor cells by
blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as
carboplatin, work in different ways to stop the growth of tumor cells, either by killing the
cells, by stopping them from dividing, or by stopping them from spreading. It is not yet
known whether veliparib is more effective with or without carboplatin in treating breast
cancer.